CRYOPORT, INC. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
CRYOPORT, INC. (CYRX) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of -$18.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-05-05
- CRYOPORT, INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-03-31 was -$18.00K.
- CRYOPORT, INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-03-31 was -$263.00K.
- CRYOPORT, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2025 was $263.00K, a 286.76% increase from fiscal 2024.
- CRYOPORT, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2024 was $68.00K, a 91.63% decline from fiscal 2023.
- CRYOPORT, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2023 was $812.00K, a 712.00% increase from fiscal 2022.
- CRYOPORT, INC. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2022 was $100.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month as first filed | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|
| 2026-03-31 | -$18.00K 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $263.00K 10-K · filed 2026-03-05 | |||
| 2025-03-31 | -$263.00K 10-Q · filed 2026-05-05 | $45.00K 10-Q · filed 2025-05-08 | ||
| 2024-12-31 | $68.00K 10-K · filed 2026-03-05 | -$27.00K 10-K · filed 2025-03-07 | ||
| 2023-12-31 | $812.00K 10-K · filed 2025-03-07 | |||
| 2022-12-31 | $100.00K 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |